The Utility of Mitochondrial Detection Methods Applied as an Additional Tool for the Differentiation of Renal Cell Tumors

The precise differentiation of renal cell tumors (RCTs) is sometimes hard to achieve using standard imaging and histopathological methods, especially for those with eosinophilic features. It has been suggested that the vast overabundance of mitochondria, as a well-known hallmark of eosinophilic cytoplasm, and could be a characteristic of distinct tumor types with opposing clinical outcomes. Thus, we intended to explore the associations between mitochondrial distribution patterns in different RCTs, including 43 cell renal cell carcinomas (ccRCCs), 15 papillary renal cell carcinomas (pRCCs), 20 chromophobe renal cell carcinomas (chRCCs), and 18 renal oncocytomas (ROs). Tumor samples were stained with two anti-mitochondrial antibodies (mitochondrial antibody Ab-2, clone MTC02; prohibitin, II-14-10, MA5-12858), applying immunohistochemistry and immunofluorescence to define mitochondrial distribution patterns (coarse scanty, moderate granular, and diffuse granular). Our results revealed significantly different expression patterns among the investigated RCTs (p < 0.001). The majority of ccRCCs exhibited coarse scanty mitochondrial staining, while all chRCCs had moderate granular expression. Nevertheless, all ROs, all pRCCs, and two cases of ccRCC presenting with higher nuclear grade and eosinophilic cytoplasm had diffuse granular mitochondrial expression. Moreover, with increased distribution of mitochondria, the intensity of staining was higher (p < 0.001). Here we present a strategy that utilizes fast and easy mitochondrial detection to differentiate RO from chRCC, as well as other eosinophilic variants of RCC with high accuracy.

[1]  C. Hoyt,et al.  Companion diagnostic requirements for spatial biology using multiplex immunofluorescence and multispectral imaging , 2023, Frontiers in Molecular Biosciences.

[2]  I. Meinhold-Heerlein,et al.  Multiplex Immunofluorescence: A Powerful Tool in Cancer Immunotherapy , 2023, International journal of molecular sciences.

[3]  M. Rubin,et al.  The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. , 2022, European urology.

[4]  A. Aguilar-Vázquez,et al.  Ten Approaches That Improve Immunostaining: A Review of the Latest Advances for the Optimization of Immunofluorescence , 2022, International journal of molecular sciences.

[5]  J. Cheville,et al.  New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia , 2021, Modern Pathology.

[6]  Yuehua Wu,et al.  Sporadic Oncocytic Tumors with Features Intermediate between Oncocytoma and Chromophobe Renal Cell Carcinoma: Comprehensive Clinico-Pathological and Genomic Profiling , 2020, medRxiv.

[7]  W. Yong,et al.  An Introduction to Performing Immunofluorescence Staining. , 2018, Methods in molecular biology.

[8]  Dijana Cerjan,et al.  Characteristics of the tissue section that influence the staining outcome in immunohistochemistry , 2018, Histochemistry and Cell Biology.

[9]  S. Nasr,et al.  Paraffin Immunofluorescence: A Valuable Ancillary Technique in Renal Pathology , 2018, Kidney international reports.

[10]  N. Golić,et al.  The Role of Macrophage Migration Inhibitory Factor in the Function of Intestinal Barrier , 2018, Scientific Reports.

[11]  A. Wu Oncocytic Renal Neoplasms on Resections and Core Biopsies: Our Approach to This Challenging Differential Diagnosis. , 2017, Archives of pathology & laboratory medicine.

[12]  B. Delahunt,et al.  Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists. , 2017, Human pathology.

[13]  Chan-Sik Park,et al.  Immunohistochemistry for Pathologists: Protocols, Pitfalls, and Tips , 2016, Journal of pathology and translational medicine.

[14]  I. Zaletel,et al.  Expression of p300 and p300/CBP associated factor (PCAF) in actinic keratosis and squamous cell carcinoma of the skin. , 2016, Experimental and molecular pathology.

[15]  E. White,et al.  Mitochondria and Cancer. , 2016, Molecular cell.

[16]  S. Truchet,et al.  Indirect Immunofluorescence on Frozen Sections of Mouse Mammary Gland. , 2015, Journal of visualized experiments : JoVE.

[17]  P. Walker,et al.  Paraffin immunofluorescence in the renal pathology laboratory: more than a salvage technique , 2015, Modern Pathology.

[18]  D. Lindgren,et al.  Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-Bromopyruvate , 2015, Cell Death and Disease.

[19]  M. Oya,et al.  Chromophobe renal cell carcinoma, oncocytic variant: a proposal of a new variant giving a critical diagnostic pitfall in diagnosing renal oncocytic tumors , 2013, Medical Molecular Morphology.

[20]  M. Yusenko Molecular pathology of chromophobe renal cell carcinoma: A review , 2010, International journal of urology : official journal of the Japanese Urological Association.

[21]  M. Selig,et al.  Use of Electron Microscopy in Core Biopsy Diagnosis of Oncocytic Renal Tumors , 2010, Ultrastructural pathology.

[22]  M. Scialpi,et al.  Electron microscopy: the gold standard in the differential diagnosis of chromophobe renal cell carcinoma and oncocytoma. , 2010, Analytical and quantitative cytology and histology.

[23]  S. Singh,et al.  Sub-typing of renal cell tumours; contribution of ancillary techniques , 2009, Diagnostic pathology.

[24]  M. Gulluoglu,et al.  Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis , 2005, Virchows Archiv.

[25]  P. Tamboli,et al.  Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray , 2004, Histopathology.

[26]  S. Tickoo,et al.  Ultrastructural Observations on Mitochondria and Microvesicles in Renal Oncocytoma, Chromophobe Renal Cell Carcinoma, and Eosinophilic Variant of Conventional (Clear Cell) Renal Cell Carcinoma , 2000, The American journal of surgical pathology.

[27]  S. Tickoo,et al.  Antimitochondrial antibody (113-1) in the differential diagnosis of granular renal cell tumors. , 1997, The American journal of surgical pathology.

[28]  S. Störkel,et al.  The human chromophobe cell renal carcinoma: Its probable relation to intercalated cells of the collecting duct , 1988, Virchows Archiv. B, Cell pathology including molecular pathology.

[29]  K. Mai,et al.  Chromophobe cell carcinoma and renal cell neoplasms with mucin-like changes. , 2000, Acta histochemica.